The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo
Open accessAbstract
Type III interferons (IFNs) (interleukin-28/29 or lambda interferon [IFN-λ]) are cytokines with IFN-like activities. Here we show that several classes of viruses induce expression of IFN-λ1 and -λ2/3 in similar patterns. The IFN-λs were—unlike alpha/beta interferon (IFN-α/β)—induced directly by stimulation with IFN-α or -λ, thus identifying type III IFNs as IFN-stimulated genes. In vitro assays revealed that IFN-λs have appreciable antiviral activity against encephalomyocarditis virus (EMCV) but limited activity against herpes simplex virus type 2 (HSV-2), whereas IFN-α potently restricted both viruses. Using three murine models for generalized virus infections, we found that while recombinant IFN-α reduced the viral load after infection with EMCV, lymphocytic choriomeningitis virus (LCMV), and HSV-2, treatment with recombinant IFN-λ in vivo did not affect viral load after infection with EMCV or LCMV but did reduce the hepatic viral titer of HSV-2. In a model for a localized HSV-2 infection, we further found that IFN-λ completely blocked virus replication in the vaginal mucosa and totally prevented development of disease, in contrast to IFN-α, which had a more modest antiviral activity. Finally, pretreatment with IFN-λ enhanced the levels of IFN-γ in serum after HSV-2 infection. Thus, type III IFNs are expressed in response to most viruses and display potent antiviral activity in vivo against select viruses. The discrepancy between the observed antiviral activity in vitro and in vivo may suggest that IFN-λ exerts a significant portion of its antiviral activity in vivo via stimulation of the immune system rather than through induction of the antiviral state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A., O'Garra, A., Biron, C., Brière, F., et al. (2001) · Nature Immunology · doi:10.1038/ni736 · Cited by 1,022
Sen, G. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.255 · Cited by 968
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali-Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 965
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 667
Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D., & Mescher, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4465 · Cited by 630
Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., & Uzé, G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324610 · Cited by 490
Taniguchi, T., & Takaoka, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00305-3 · Cited by 482
Battegay, M., Cooper, S., Althage, A., Bänziger, J., Hengartner, H., & Zinkernagel, R. M. (1991) · Journal of Virological Methods · doi:10.1016/0166-0934(91)90018-u · Cited by 475
Interferon‐Induced Mx Proteins: Dynamin‐Like GTPases with Antiviral Activity
Haller, O., & Kochs, G. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.31003.x · Cited by 460 · cited 1×
“, blockage of viral entry into the cell, control of viral transcription, cleavage of RNA, and preventing translation (16, 31, 37).”
BackgroundSpann, K. M., Tran, K.-C., Chi, B., Rabin, R. L., & Collins, P. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4363-4369.2004 · Cited by 447
Lambda Interferon Inhibits Hepatitis B and C Virus Replication
Robek, M. D., Boyd, B. S., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3851-3854.2005 · Cited by 431
Interferons Regulate the Phenotype of Wild-type and Mutant Herpes Simplex Viruses In Vivo
Leib, D. A., Harrison, T. E., Laslo, K. M., Machalek, M. A., Moorman, N. J., & Virgin, H. W. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.663 · Cited by 341
Production of type I interferons
Asselin-Paturel, C., & Trinchieri, G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051395 · Cited by 305
Dumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., & Renauld, J.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404789200 · Cited by 291
Pirhonen, J., Sareneva, T., Kurimoto, M., Julkunen, I., & Matikainen, S. (1999) · PubMed · Cited by 274
Interferon Action in Triply Deficient Mice Reveals the Existence of Alternative Antiviral Pathways
Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R. G., & Silverman, R. H. (1999) · Virology · doi:10.1006/viro.1999.9738 · Cited by 244
Liu, T., Khanna, K. M., Carriere, B. N., & Hendricks, R. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11178-11184.2001 · Cited by 243
Initial and innate responses to viral infections — pattern setting in immunity or disease
A Biron, C. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)80066-6 · Cited by 239
IFN-α Regulates TLR-Dependent Gene Expression of IFN-α, IFN-β, IL-28, and IL-29
Sirén, J., Pirhonen, J., Julkunen, I., & Matikainen, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1932 · Cited by 238
Pirhonen, J., Sareneva, T., Kurimoto, M., Julkunen, I., & Matikainen, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7322 · Cited by 235
Biological activity of interleukins-28 and -29: Comparison with type I interferons
MEAGER, A., VISVALINGAM, K., DILGER, P., BRYAN, D., & WADHWA, M. (2005) · Cytokine · doi:10.1016/j.cyto.2005.04.003 · Cited by 220
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J.-M., Diebold, J., Diepolder, H., Adler, B., Auernhammer, C. J., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00126.2005 · Cited by 205
Österlund, P., Veckman, V., Sirén, J., Klucher, K. M., Hiscott, J., Matikainen, S., & Julkunen, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9608-9617.2005 · Cited by 183
Ou, R., Zhou, S., Huang, L., & Moskophidis, D. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8407-8423.2001 · Cited by 175
Melchjorsen, J., Sirén, J., Julkunen, I., Paludan, S. R., & Matikainen, S. (2006) · Journal of General Virology · doi:10.1099/vir.0.81541-0 · Cited by 164
Self-citationHarandi, A. M., Eriksson, K., & Holmgren, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.953-962.2003 · Cited by 161
Self-citationAshkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., & Rosenthal, K. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8948-8956.2003 · Cited by 155
Taylor, E. B., Lamb, J. D., Hurst, R. W., Chesser, D. G., Ellingson, W. J., Greenwood, L. J., Porter, B. B., Herway, S. T., & Winder, W. W. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2005 · Cited by 126
Bartlett, N., Buttigieg, K., Kotenko, S., & Smith, G. L. (2005) · Journal of General Virology · doi:10.1099/vir.0.80904-0 · Cited by 117
Harandi, A. M., Svennerholm, B., Holmgren, J. R., & Eriksson, K. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6705-6709.2001 · Cited by 90
Self-citationHommes, D. W., Baert, F., Assche, G. V., Caenepeel, F., Vergauwe, P. L., Tuynman, H. A. R. E., Vos, M. D., van Deventer, S. J. H., Stitt, L., Rutgeerts, P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.064 · Cited by 59
CD8+ T-cell priming regulated by cytokines of the innate immune system
Stäger, S., & Kaye, P. M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.003 · Cited by 23
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J., Göke, B., Diepolder, H. M., Adler, B., Auernhammer, C. J., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.062 · Cited by 8
Cited by
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
“PKR is constitutively expressed in all tissues at a basal level and is upregulated by type I and type III IFN”
BackgroundImmune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,826
Rauch, A., Kutalik, Z., Descombes, P., Cai, T., Di Iulio, J., Mueller, T., Bochud, M., Battegay, M., Bernasconi, E., Borovicka, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.056 · Cited by 1,137
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Metadata
- Authors
- Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., & Paludan, S. R.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-05
- Volume
- 80
- Issue
- 9
- Pages
- 4501-4509
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2107830237
- Cited by
- 596
- References
- 40
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.